Last edition
News about "This strategic acquisition brings Sanofi a commerc"
Sanofi Completes Acquisition of Blueprint Medicines, Expands Rare Immunology Portfolio
This strategic acquisition brings Sanofi a commercialised treatment, a promising pipeline, and deep scientific expertise in SM and related diseases. It also enhances Sanofi’s footprint across allergy, dermatology, and immunology specialities, bolstering its expanding immunology pipeline.
This Strategic Acquisition Brings Sanofi A Commerc | 19/07/2025 | By Darshana | 153
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members